Five-year report from the Polish national registry on percutaneous coronary interventions with a focus on coronary artery perforations within chronic total occlusions

• Published in: Postępy w kardiologii interwencyjnej Vol. 16; no. 4; pp. 399 - 409
• Main Authors: Januszek, Rafał, Bryniarski, Leszek, Siudak, Zbigniew, Malinowski, Krzysztof P, Bryniarski, Krzysztof L, Surdacki, Andrzej, Dziewierz, Artur, Mika, Piotr, Wańha, Wojciech, Wojakowski, Wojciech, Wójcik, Jarosław, Legutko, Jacek, Bartuś, Stanisław
• Format: Journal Article
• Language: English
• Published: Poland Termedia Publishing House 01.12.2020
• Subjects: Angioplasty; Cardiology; chronic total occlusion; coronary artery perforations; Coronary vessels; Hospitals; Intervention; Laboratories; Monte Carlo simulation; Original Paper; percutaneous coronary intervention; periprocedural complications; Stents; Veins & arteries; periprocedural complications; percutaneous coronary intervention; chronic total occlusion; coronary artery perforations
• ISSN: 1734-9338; 1897-4295
• DOI: 10.5114/aic.2020.101764

Patients treated within chronic total occlusions (CTO) using percutaneous coronary intervention (PCI) are at increased risk of periprocedural complications. To assess the frequency of periprocedural complications with particular emphasis on coronary artery perforations (CAPs) among patients treated with PCIs stratified according to CTOs and their predictors. Based on a nationwide registry (ORPKI), we analysed 535,853 patients treated with PCI between 2014 and 2018. The study included 12,572 (2.34%) patients treated with CTO PCI. We compared CTO PCI to a non-CTO PCI group before and after propensity score matching (PSM). Multifactorial mixed regression models were used to assess predictors of periprocedural complications and CAPs which occurred within the catheterization laboratory. Frequencies of all periprocedural complications (2.75% vs. 1.93%, < 0.001) and CAP (0.72% vs. 0.16%, < 0.001) were significantly higher in the CTO PCI group. Multifactorial regression analysis performed in the all-comers group of patients treated with PCI showed that PCI within CTO was related to a higher CAP rate (odds ratio (OR) = 2.18; 95% confidence interval (CI): 1.68-2.82, < 0.001). After PSM, we extracted 5,652 patients treated within CTO and 5,652 patients with non-CTO PCI. CTO PCI was also related to a higher frequency of CAPs (OR = 1.89; 95% CI: 1.11-3.31, = 0.01). The frequency of periprocedural complications and CAPs remained stable during the assessed period of time. CTO PCI was confirmed to be among the predictors of increased CAP rate in the overall group of patients treated within CTO.